Winner Profile
Dr. Jean-Paul Clozel

CEO, formerly at Actelion

Industry: Biotechnology
Company size: Large
Published: 2016-07-17

Is Actelion a good stock investment?

Obermatt Stock Research Actelion


Based on the annual Obermatt CEO of the Year analysis, Dr. Jean-Paul Clozel (for his work at Actelion) earned the following Obermatt pins for the management performance.

Obermatt accolades Dr. Jean-Paul Clozel

Dr. Jean-Paul Clozel is not included in a current Obermatt competition.

Performance Overview Dr. Jean-Paul Clozel

In summary, Dr. Jean-Paul Clozel obtained the following performances in the individual Obermatt categories over six participations in the Obermatt rankings (averages of all evaluated rankings are shown):

CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 72 in Combined Performance indicates that Dr. Jean-Paul Clozel was better than 72% of all other CEOs that were analyzed as part of the Large Companies – Switzerland for 6 participations in Obermatt CEO competitions. Dr. Jean-Paul Clozel’s average ranking can be found in the Multi-Year Rankings for Large Companies - Switzerland.